SCHEMBL6882846

SCHEMBL6882846

CCOC(=O)C1CCC(CNC(=O)c2cc(Br)cs2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MMP12 P39900 1/20 0.45
GNRHR P30968 1/20 0.45
HDAC4 P56524 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 2/20 0.40
MAPK1 P28482 2/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
F10 P00742 1/20 0.40
TAS2R14 Q9NYV8 1/20 0.39
TP53 P04637 2/20 0.39
HRH3 Q9Y5N1 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6883378 0.85 MEN1 (0.44) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6882179 0.83 MMP12 (0.57) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6455748 0.83 MMP12 (0.58) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6882247 0.82 MMP12 (0.56) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6878595 0.81 MMP12 (0.55) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6878598 0.81 MMP12 (0.55) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6370857 0.78 MMP12 (0.78) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL6370860 0.78 MMP12 (0.78) MEN1KMT2AMMP12GNRHRHDAC4
SCHEMBL15158080 0.73 MEN1 (0.51) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL15534935 0.73 MEN1 (0.47) MEN1KMT2AGNRHRALDH1A1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them MMP11, MMP13, CBR1 MEN1 4862/4885KMT2A 4610/4885MMP12 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.